|
RPS6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.655740E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.076000E-02 |
| Normal-vs-Stage2 |
9.445900E-02 |
| Normal-vs-Stage3 |
4.375600E-02 |
| Normal-vs-Stage4 |
3.316200E-03 |
| Stage1-vs-Stage2 |
5.093200E-01 |
| Stage1-vs-Stage3 |
4.008000E-01 |
| Stage1-vs-Stage4 |
8.060600E-03 |
| Stage2-vs-Stage3 |
9.273800E-01 |
| Stage2-vs-Stage4 |
5.196100E-03 |
| Stage3-vs-Stage4 |
1.453660E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.757300E-03 |
| Normal-vs-AfricanAmerican |
5.042600E-03 |
| Normal-vs-Asian |
2.946600E-01 |
| Caucasian-vs-AfricanAmerican |
7.374400E-01 |
| Caucasian-vs-Asian |
8.551600E-01 |
| AfricanAmerican-vs-Asian |
9.357600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.020300E-03 |
| Normal-vs-Female |
9.361100E-03 |
| Male-vs-Female |
9.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.196500E-03 |
| Normal-vs-Extreme_Weight |
8.541900E-03 |
| Normal-vs-Obese |
7.656600E-03 |
| Normal-vs-Extreme_Obese |
5.975600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.959000E-01 |
| Normal_Weight-vs-Obese |
5.534800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.135200E-01 |
| Extreme_Weight-vs-Obese |
6.539600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.876800E-01 |
| Obese-vs-Extreme_Obese |
4.588200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.236500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.623600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.116220E-02 |
| Normal-vs-Age(81-100Yrs) |
4.633600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.421600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.075600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.069800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.035400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.376200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.241800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.942800E-03 |
| Normal-VS-Type2 PRCC |
6.382100E-02 |
| Normal-VS-KIRP CIMP |
4.755700E-03 |
| Normal-VS-Unclassified PRCC |
3.870400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.226400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.422000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.034800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.194390E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.415400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.422700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.659500E-02 |
| Normal-vs-N1 |
9.298900E-03 |
| Normal-vs-N2 |
2.418200E-01 |
| N0-vs-N1 |
1.184770E-01 |
| N0-vs-N2 |
1.076210E-01 |
| N1-vs-N2 |
6.544400E-01 |
|
|
